Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye
ConditionDry Eye Syndromes
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorIran University of Medical Sciences
About this trial
The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms
Eligibility criteria
Qualifiers
Patients with complaints of burning or itching or feeling of a foreign body in the eye
Moderate and severe dry eye severity
Age between 18-70 years
Disqualifiers
Previous history of eye surgery
Any disease that suppresses the immune system
Pregnancy and breastfeeding
Eyelid abnormalities
Trial design
Treatments tested in this trial
- Limbal Stem Cell Derived Exosomes Eye Drop
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov